Table 3.
Comparison of study data with prevalence in median age group according to current data from Germany
| Our data | Prevalence in median age group | |
|---|---|---|
| Sex (m:f) |
117:142; 55% female |
prevalence for PG: 0.3-1.0/100.000 |
| (Germany: 1000:1040; 51% female) | ||
| Age (mean) |
21-94 years (57.3 years) |
|
| (Germany, 2010: 44.3 years) | ||
|
Associated inflammatory disorders | ||
| Arthrosis, non rheumatoid arthritis |
17 (6.6%) |
female (45–65 years): 33% |
| male: (45–65 years): 25% | ||
| Rheumatoid arthritis |
24 (9.3%) |
female (45–64 years): 8.6% |
| male (45–64 years): 5% | ||
| overall: 0.5-0.8% | ||
| Chronic inflammatory bowel disease |
Overall: 24 (9.3%) |
Crohn’s disease: |
| Crohn’s disease: |
120-200/100.000 |
|
| 7 (2.7%) |
Ulcerative colitis: |
|
| Ulcerative colitis: 17 (6.6%) |
160-250/100.000 |
|
|
Endocrine disorders | ||
| Thyroid disease |
29 (11.2%) |
overall: 5.5% |
| female: 8.9% | ||
| male: 1.8% | ||
| Diabetes mellitus |
66 (25.5%) |
international overall (20–79 years): 12% |
| German overall: 8.9% | ||
| Neoplasia |
32 (12.4%) |
overall: 5-yr.-prevalence: 1.6% |
| 10-yr.-prevalence: 2.4% | ||
|
Solid neoplasms (overall) |
22 (8.5%) |
|
| Breast cancer |
6 (2.3%) |
female (50–59 years): 1-year-prevalence: 0.2% |
| Lung cancer |
3 (1.6%) |
female: 50–59 years: 1-year-prevalence: 0.04% |
| male: 50–59 years: 1-year-prevalence: 0.07% | ||
| Prostate cancer |
3 (1.6%) |
male overall: 1-year-prevalence: 0.1% |
| male (60–69 years): 1-year- prevalence: 0.5% | ||
| Melanoma |
3 (1.6%) |
female (50–59 years): 1-year.-prevalence: 0.03% |
| male (50–59 years): 1-year life-prevalence: 0.02% | ||
| Hepatocellular carcinoma |
2 (0.8%) |
overall: 7-8/100.000 |
| Ovarian cancer |
2 (0.8%) |
female (50–59 years): 1-year life-prevalence: 0.03% |
| Colon cancer |
1 (0.4%) |
female (50–59 years): 1-year.-prevalence: 0.1% |
| male (50–59 years): 1-year-prevalence: | ||
| Laryngeal cancer |
1 (0.4%) |
female: 1-year-prevalence: <0.01% |
| male: 1-year-prevalence: <0.1% | ||
| Glioblastoma multiforme |
1 (0.4%) |
n.a. |
|
Hematologic/hematopoetic neoplasia |
|
Leukemia, female:1-year-prevalence: 0.01% |
| AML |
1 (0.4%) |
|
| CML |
2 (0.8%) |
Leukemia, male: |
| Other | 7 (2.8%) | 1-year-prevalence: 0.01% |